Amir Nashat - 18 May 2022 Form 4 Insider Report for Metacrine, Inc.

Reporting relationship: Director, 10%+ Owner
Issuer ticker: N/A
Reported as of: 18 May 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Sep 2022, 19:27:53 UTC
Prior SEC filing: 19 Nov 2021
Next SEC filing: 27 May 2022
Source filing: View source filing
Reporting owner signature: /s/ Michael York, Attorney-in-fact

Key filing fact

Amir Nashat filed Form 4 for Metacrine, Inc. on 06 Sep 2022.

Key facts

This page summarizes Amir Nashat's Form 4 filing for Metacrine, Inc..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 06 Sep 2022, 19:27.

Change

Previous filing in this sequence was filed on 19 Nov 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MTCR transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +16,500
Change %
Price: $0.000000
Shares after: 16,500
Date: 18 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 16,500
Exercise price: $0.4200
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day immediately prior to the date of the Issuer's 2023 annual meeting of stockholders.